AQST News and Press, Aquestive Therapeutics Inc. From 11/26/19

Company to Host Scientific Exhibit on Monday, December 9 from 8:00 am ET to 11:00 am ET Company to Host Investor & Analyst Libervant Update Forum and Webcast on Monday, December 9 at 4:00 pm ET WARREN, N.J., Nov. 26, 2019 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NA...

Gainers:  JanOne (NASDAQ: JAN ) +103% . More news on: JanOne Inc., Sorrento Therapeutics, Inc., The Peck Company Holdings, Inc., Stocks on the move, Read more ...

JanOne (NASDAQ: JAN ) +127%  on acquiring worldwide license for treatment of Peripheral Arterial Disease. More news on: JanOne Inc., Sorrento Therapeutics, Inc., The Medicines Company, Stocks on the move, Read more ...

WARREN, N.J., Nov. 25, 2019 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products to solve therapeutic problems, today announced that Exservan™ (riluzole) Oral Film receive...

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks, and our single stock focus. If you are interested in listening to Stocks To Watch ...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

Aquestive Therapeutics (NASDAQ: AQST ) is up 14.3% after hours following FDA approval for Exservan, its riluzole oral film for patients with ALS. More news on: Aquestive Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...

The following slide deck was published by Aquestive Therapeutics, Inc. in conjunction with their 2019 Q3 earnings Read more ...

WARREN, N.J., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products that meet patients’ unmet needs and solve therapeutic problems, today announced that it gr...

Aquestive Therapeutics, Inc. (AQST) Q3 2019 Earnings Conference Call November 06, 2019 08:00 AM ET Company Participants Stephanie Carrington - Westwicke Investor Relations Keith Kendall - Chief Executive Officer John Maxwell - Chief Financial Officer Ken Marshall - Chief Commer...